BP
Ballentine Partners Portfolio holdings
AUM
$6.64B
This Quarter Return
+1.21%
1 Year Return
+16.37%
3 Year Return
+60.04%
5 Year Return
+90.6%
10 Year Return
+147.86%
AUM
$1.19B
AUM Growth
+$1.19B
(+4.6%)
Cap. Flow
+$39.8M
Cap. Flow
% of AUM
3.35%
Top 10 Holdings %
Top 10 Hldgs %
70.04%
Holding
248
New
15
Increased
82
Reduced
97
Closed
9
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$20M |
| 2 |
LKQ Corp
LKQ
|
$11.2M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
$9.18M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$8.4M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$4.64M |
Top Sells
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$4.77M |
| 2 |
EIGI
Endurance International Group Holdings, Inc.
EIGI
|
$4.66M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$1.99M |
| 4 |
Yum! Brands
YUM
|
$550K |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$513K |
Sector Composition
| 1 | Industrials | 1.95% |
| 2 | Consumer Discretionary | 1.88% |
| 3 | Healthcare | 1.47% |
| 4 | Technology | 1.41% |
| 5 | Financials | 1.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Accenture
ACN
$162B
| $527K | 0.04% | 4,653 +129 | +3% | +$14.6K |
|
102
Nike
NKE
$114B
| $525K | 0.04% | 9,536 -249 | -3% | -$13.7K |
|
|
WBA
103
DELISTED
Walgreens Boots Alliance
WBA
| $520K | 0.04% | 6,251 -1,421 | -19% | -$118K |
|
|
ESRX
104
DELISTED
Express Scripts Holding Company
ESRX
| $520K | 0.04% | 6,856 +26 | +0.4% | +$1.97K |
|
105
Bank of New York Mellon
BK
$74.5B
| $512K | 0.04% | 13,152 +267 | +2% | +$10.4K |
|
106
Invesco QQQ Trust
QQQ
$364B
| $512K | 0.04% | 4,763 | – | – |
|
107
Schlumberger
SLB
$55B
| $500K | 0.04% | 6,304 +781 | +14% | +$61.9K |
|
108
Amgen
AMGN
$155B
| $494K | 0.04% | 3,248 +34 | +1% | +$5.17K |
|
|
Y
109
DELISTED
Alleghany Corporation
Y
| $493K | 0.04% | 896 -29 | -3% | -$16K |
|
110
SPDR S&P Dividend ETF
SDY
$20.6B
| $489K | 0.04% | 5,825 -760 | -12% | -$63.8K |
|
111
AbbVie
ABBV
$372B
| $486K | 0.04% | 7,853 +663 | +9% | +$41K |
|
112
Target
TGT
$43.6B
| $485K | 0.04% | 6,927 +620 | +10% | +$43.4K |
|
|
CELG
113
DELISTED
Celgene Corp
CELG
| $483K | 0.04% | 4,892 -135 | -3% | -$13.3K |
|
114
Vanguard S&P 500 ETF
VOO
$726B
| $482K | 0.04% | 2,509 | – | – |
|
115
Toronto Dominion Bank
TD
$128B
| $480K | 0.04% | 11,187 +16 | +0.1% | +$687 |
|
116
Biogen
BIIB
$19.4B
| $476K | 0.04% | 1,965 +154 | +9% | +$37.3K |
|
117
Vanguard Growth ETF
VUG
$185B
| $465K | 0.04% | 4,340 | – | – |
|
118
US Bancorp
USB
$76B
| $459K | 0.04% | 11,355 +137 | +1% | +$5.54K |
|
119
Danaher
DHR
$147B
| $457K | 0.04% | 4,506 +137 | +3% | +$13.9K |
|
120
Union Pacific
UNP
$133B
| $450K | 0.04% | 5,164 -1 | -0% | -$87 |
|
121
Banco Santander
SAN
$141B
| $442K | 0.04% | 112,682 +47 | +0% | +$184 |
|
122
Novo Nordisk
NVO
$251B
| $425K | 0.04% | 7,909 +142 | +2% | +$7.63K |
|
123
GSK
GSK
$79.9B
| $423K | 0.04% | 9,752 -1,025 | -10% | -$44.5K |
|
124
Analog Devices
ADI
$124B
| $420K | 0.04% | 7,424 -272 | -4% | -$15.4K |
|
125
Novartis
NVS
$245B
| $417K | 0.04% | 5,056 +577 | +13% | +$47.6K |
|